Endologix Denies Elliott Associates' Buyout Offer

November 13th, 2008
| More
Endologix Inc. (NASDAQ:ELGX), developer of the Powerlink(R) system, announced today that its Board of Directors has unanimously decided to deny the $98 million offer it received in October from activist hedge fund manager Elliott Associates. The press release said that the Board came to the conclusion after careful consideration and after receiving advice from bankers at Piper, Jaffray & Co. John McDermott, president and CEO commented that although the offer from Elliot Associates was much appreciated, it didn’t match the potential of the company and the positive developments it had made in 2008 such as the recent FDA product approvals.
See Press Release
For Detailed Investor Profiles on these Investors, click below:
Elliott Management Corporation
Related People: Brian Miller*; Gordon Singer; Jon Pollock; Paul Singer
Related Entities: Elliott Associates; Elliott International; Elliott Management Corp
Related Article Tags: Shareholder Activists, Corporate Raiders and Proxy Battles

More Recent Headlines

Elliot Associates Offers $98 million for Endologix


Warren Buffett Unplugged

Black, blue and white swans: Comments on Nassim Taleb

Crosslink's Michael Stark on Investing in Volatile Markets

Steel Partners makes offer for Noritz

Sun-Times Media Faces Another Activist: Davidson Kempner Capital Management

Icahn vs. Lipton

Sandell Joins Efforts to Reshape ASM International

KDB is Looking to Buy a Global Bank